Skip to main content
SunBio, Inc. logo

SunBio, Inc. — Investor Relations & Filings

Ticker · 067370 ISIN · KR7067370007 KO Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2022-11-17 Report Publication Anno…
Country KR South Korea
Listing KO 067370

About SunBio, Inc.

http://www.sunbio.com/

SunBio, Inc. is a biotechnology company that develops biosimilars, biopharmaceuticals, and medical devices. The company's core activities are based on its proprietary PEGylation technology, a process that modifies molecules to enhance their therapeutic properties. SunBio's product portfolio includes PEG reagents for research and drug delivery, as well as biopharmaceutical candidates. Key development projects include MucoPEG™, a muco-adhesive hydrogel, and SBX, an artificial blood substitute. The company positions itself as a specialist in PEGylation, creating advanced therapeutic products for a global market.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location (online link), and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it is under 5,000 characters, it falls under the category of a report or event publication announcement.
2022-11-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is the standard Korean regulatory filing for disclosing significant ownership stakes (often referred to as the 5% rule). This document details the shareholding status, changes in ownership, and the purpose of holding (management influence) for the reporter and their special related parties. It is a formal regulatory disclosure required by the Capital Markets Act, fitting the 'Major Shareholding Notification' category.
2022-11-16 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'SunBio' (선바이오(주)) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, capital structure, and management details, which is characteristic of a formal quarterly financial filing in the Korean market. It is not an announcement of a report (RPA) or a simple certification, but the full report itself. 9M 2022
2022-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details specific share transactions (market purchases) made by a director (CEO Noh Kwang) of SunBio Co., Ltd. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes, which corresponds to the 'Director's Dealing' category.
2022-10-17 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used when an entity's shareholding in a company crosses specific thresholds (typically 5%). This document details the shareholding changes of (주)이수화학 in 선바이오(주). Since this is a specific regulatory disclosure regarding share ownership thresholds rather than a general announcement or a report publication notice, it falls under the 'Major Shareholding Notification' category.
2022-09-28 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing in South Korea required when an entity's shareholding in a company crosses certain thresholds (typically 5%). This document details the changes in shareholding by (주)이수화학 in 선바이오(주) due to market transactions and capital changes. This falls under the 'Major Shareholding Notification' category.
2022-09-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.